Ion Channels and Neurological Disease

doi:10.3390/books978-3-7258-1930-0

Format

Hardback

License and Copyright

Keywords

ryanodine receptor; autophagy; calcium signaling; calcineurin; Alzheimer’s disease; Nav channel blockers; epilepsy; FHM3; intellectual disability; neurodegeneration; Alzheimer’s disease; Parkinson’s disease; amyotrophic lateral sclerosis; CLC proteins; endosome; lysosome; chloride transport; developmental; cerebellar ataxia; Purkinje neuron; intrinsic membrane excitability; ion channels; therapy; voltage-gated sodium channels; Alzheimer’s disease; excitability; hippocampus; neurodegeneration; plasticity; pharmacology; GABA_B receptors; spinal cord; dorsolateral funiculus afferents; motoneurons; nucleoporins; ion channels; membrane excitability; voltage-gated sodium channels; neuronal activity; neurodegenerative disease; patch-clamp; astrocytes; ion channels; glia; Alzheimer’s disease; glioblastoma; transporter; disease; brain oscillations; excitation; inhibition; Alzheimer’s disease; induced pluripotent stem cells; neurodegeneration; AMPA; glutamate; n/a

Reprint

Download Flyer

Ion Channels and Neurological Disease

Edited by

August 2024

208 pages

ISBN 978-3-7258-1929-4 (Hardback)
ISBN 978-3-7258-1930-0 (PDF)

https://doi.org/10.3390/books978-3-7258-1930-0

Free Download (PDF)

This is a Reprint of the Special Issue Ion Channels and Neurological Disease that was published in

Biology & Life Sciences

Summary

This Special Issue reprint aims to provide an update on the state of the art and new achievements in the research on altered structure/function relationship in the ion channels involved in neurological diseases’ pathophysiology. Of particular interest are drug screening and targeting, proposing novel therapeutic avenues which can be developed to treat or alleviate mostly incurable diseases. Multi- and inter-disciplinary research contributions, often combining structural, functional, and/or pharmacological approaches with different methods/techniques, are presented.